ID: ALA4644970

Max Phase: Preclinical

Molecular Formula: C57H61F3N12O10

Molecular Weight: 1131.18

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12

Standard InChI:  InChI=1S/C57H61F3N12O10/c1-38-10-11-40(33-39(38)13-15-44-35-62-49-8-4-18-63-72(44)49)53(75)64-42-14-12-41(46(34-42)57(58,59)60)36-68-20-22-69(23-21-68)51(74)9-2-5-43-37-70(67-66-43)24-26-80-28-30-82-32-31-81-29-27-79-25-19-61-47-7-3-6-45-52(47)56(78)71(55(45)77)48-16-17-50(73)65-54(48)76/h3-4,6-8,10-12,14,18,33-35,37,48,61H,2,5,9,16-17,19-32,36H2,1H3,(H,64,75)(H,65,73,76)

Standard InChI Key:  OCHJOGLRDDWDLC-UHFFFAOYSA-N

Associated Targets(Human)

Cereblon/BCR/ABL 220 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1131.18Molecular Weight (Monoisotopic): 1130.4586AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source